A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2004
11/04/2004	WO2004043387A3 Compositions and methods for cancer diagnosis and therapy
11/04/2004	WO2004043356A3 Coated dibasic calcium phosphate
11/04/2004	WO2004026259A3 Transdermal compositions
11/04/2004	WO2004003000A3 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
11/04/2004	WO2003090724A8 Coated particles with prolonged release and tablets containing same
11/04/2004	WO2003063799A3 Compositions and methods for systemic inhibition of cartilage degradation
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	US20040220553 Implantable therapeutic substance delivery device
11/04/2004	US20040220552 Implantable drug delivery systems and methods
11/04/2004	US20040220551 Low profile components for patient infusion device
11/04/2004	US20040220548 Permeable membrane catheters, systems, and methods
11/04/2004	US20040220547 Multiple infusion section catheters, systems, and methods
11/04/2004	US20040220546 Reduction of inflammatory mass with spinal catheters
11/04/2004	US20040220545 Method of delivering drugs to specific regions of the spinal cord
11/04/2004	US20040220544 Method of delivering drug to brain via spinal cord
11/04/2004	US20040220543 Trailing system for evaluation of the efficacy of the treatment
11/04/2004	US20040220529 Apparatus and methods for activating a delivery device
11/04/2004	US20040220518 Drug solution density adjustment systems and methods
11/04/2004	US20040220510 Occlusion resistant hydrocephalic shunt
11/04/2004	US20040220392 Compositions for, and methods of, treating atherosclerosis
11/04/2004	US20040220283 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
11/04/2004	US20040220277 Enantiomeric amphetamine compositions
11/04/2004	US20040220276 Coated granules of allylamine-or benzylamine-anti-mycotics
11/04/2004	US20040220262 Transdermal and topical administration of drugs using basic permeation enhancers
11/04/2004	US20040220250 Controlled release and delayed release formulations containing carvedilol; able to extend the duration of action of carvedilol, thus improving bioavailability; drug formulation comprises a hydrophilic polymer
11/04/2004	US20040220240 Method of increasing the extent of absorption of tizanidine
11/04/2004	US20040220228 Freeze-dried pantoprazole preparation and pantoprazole injection
11/04/2004	US20040220220 Method for treating inflammatory bowel disease
11/04/2004	US20040220205 Parkinson's disease; restless leg syndrome; sexual disorders
11/04/2004	US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004	US20040220160 fine particle sizes; topical applying; mixture with arginine, tocopherol and lecithin
11/04/2004	US20040220154 Topical testosterone formulations and associated methods
11/04/2004	US20040220153 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
11/04/2004	US20040220132 Treatment of neurodegenerative disease through intracranial delivery of siRNA
11/04/2004	US20040220126 hepatocyte growth factor gene as drug; topical applying ; side effect reduction; cardiovascular disorders
11/04/2004	US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds,
11/04/2004	US20040220089 Ophthalmic preparation containing glycoprotein
11/04/2004	US20040220081 Nanoparticulate bioactive agents
11/04/2004	US20040220080 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
11/04/2004	US20040219655 Nanoscale particles synthesized within an assembled virion
11/04/2004	US20040219605 Fluid planar lipid layer-based membrane-anchored ligand system with defined ligand valency and methods of use thereof
11/04/2004	US20040219360 Polymeric microspheres
11/04/2004	US20040219230 Compositions for preparing external carbon dioxide agents
11/04/2004	US20040219229 Migraine relief composition and methods of using and forming same
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219222 Method to obtain microparticles
11/04/2004	US20040219221 Nanoparticle structures
11/04/2004	US20040219220 Therapeutic agents
11/04/2004	US20040219219 Compositions containing alpha-2-adrenergic agonist components
11/04/2004	US20040219218 tablets or capsules of T3 or T4 or their salts in a uniform soft gel matrix that can be taken orally without chewing
11/04/2004	US20040219216 Controlled release oral drug delivery system
11/04/2004	US20040219213 Oral pulsed dose drug delivery system
11/04/2004	US20040219212 Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
11/04/2004	US20040219211 a tablet which disintigrates in the mouth, having enterically coated microgranules of a benzimidazole type proton pump inhibitor overcoated with a methacrylic copolymer protective coating, granular antacids, a disintegrating agent, a diluent, and a lubricant; gastrointestinal disorders
11/04/2004	US20040219210 sustained release tablets wtih a rheology modifying crosslinked polymer having acrylic (di)acid, anhydride, or monoesterified diacid monomers and optional acrylic ester or vinyl ether comonomer, an excipient, a surface active agent and a solubility enhancer
11/04/2004	US20040219209 Controlled release metformin compositions
11/04/2004	US20040219208 Sustained-release medicines
11/04/2004	US20040219206 Solid dose delivery vehicle and methods of making same
11/04/2004	US20040219205 liposomes encapsulating drugs, peptides, proteins or DNA, having phosphatide multilayer surface conjugated with ligand that recognize target cells and induce endocytosis
11/04/2004	US20040219204 Method of treating angiogenic tissue growth
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219200 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/04/2004	US20040219199 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/04/2004	US20040219198 Transdermal drug delivery device with multilayer backing
11/04/2004	US20040219197 topical mixtures of estrogens or progesterones, and drug delivery vehicles comprising alcohols, alcohols-2+ or polyoxyalylene glycols, and permeation enhancer comprising a monoalkyl ether of diethylene glycol
11/04/2004	US20040219196 multilayer patches comprising barrier layers between polymers films having drugs dispersions and drug antagonist layers, wherein the barrier is permeable to solvents and impermeable to diffusion of drugs and drug antagonist in the absence of solvent; protective devices
11/04/2004	US20040219195 multilayer patches comprising barrier layers between polymers films having drugs dispersions and drug antagonist layers, wherein the barrier is permeable to solvents and impermeable to diffusion of drugs and drug antagonist in the absence of solvent; protective devices
11/04/2004	US20040219194 comprising drug impervious coverings, matrices containing aloe vera extracts, 4-diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate and/or racemic mixtures, release linings, pressure sensitive adhesive and curing agents for the adhesive.
11/04/2004	US20040219192 transdermal patches having backing layers, drug reservoirs and on the surface facing the skin a drug permeable electric heaters, controllers and power sources, used for administering drugs or cosmetics to humans or animals
11/04/2004	US20040219191 Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by dopaminergic means
11/04/2004	US20040219187 biodegradable prosthetics having coatings selected from retinol, retinal, retinoic acid or p-[(E)-2-(5, 6, 7, 8-tetrahydro-5, 5, 8, 8-tetramethyll-2-naphthyl)propenyl]-benzoic acid, used as grafts for eye tissues
11/04/2004	US20040219186 time release agents comprising gel formed from polysaccharides, excipients and drugs
11/04/2004	US20040219185 Method for making a porous polymeric material
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219175 Thermogelling emulsions for sustained release of bioactive substances
11/04/2004	US20040219174 Contraception process and administration form for the same
11/04/2004	US20040219114 Cream for treatment of skin injured by the sun
11/04/2004	US20040219109 including, but not limited to, silk screen printing, ink jet printing, offset printing, and/or other printing or transfer processes in various unique colors and/or patterns
11/04/2004	US20040219108 Powdery composition for nasal administration
11/04/2004	US20040219107 The applicator assembly includes a sleeve that encases a swab having a portion that contacts a gelled composition; the sleeve is manually severed to expose the applicator and the composition
11/04/2004	US20040219106 Compounds for use as surfactants
11/04/2004	US20040218345 Products comprising nano-precision engineered electronic components
11/04/2004	US20040217200 Aerosol product
11/04/2004	DE29825080U1 Pharmazeutische Fenofibratzusammensetzung mit erhöhter Bioverfügbarkeit Pharmaceutical fenofibrate with increased bioavailability
11/04/2004	DE10315878A1 Transdermale Verabreichung von (R)-3,3-Diphenylpropylamin-Monoestern Transdermal administration of (R) -3,3-diphenylpropylamine monoesters
11/04/2004	CA2838369A1 Sequestered reactive materials
11/04/2004	CA2821376A1 Magnetically controllable drug and gene delivery stents
11/04/2004	CA2821220A1 Magnetically controllable drug and gene delivery stents
11/04/2004	CA2821214A1 Magnetically controllable drug and gene delivery stents
11/04/2004	CA2746531A1 Non-steroidal anti-inflammatory drug dosing regimen
11/04/2004	CA2523957A1 Sequestered reactive materials
11/04/2004	CA2523218A1 Oral pharmaceutical formulations of acid-labile active ingredients and process for making same
11/04/2004	CA2522891A1 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	CA2522662A1 Compositions for delivery of drug combinations
11/04/2004	CA2522625A1 Magnetically controllable drug and gene delivery stents
11/04/2004	CA2522158A1 Devices and apomorphine pharmaceutical compositions for enhancing dosingefficiency
11/04/2004	CA2521531A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	CA2520886A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors

1 ... 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 ... 2991